140 related articles for article (PubMed ID: 19238931)
21. Understanding osteoporosis.
Javaid MK; Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):38-45. PubMed ID: 18477619
[TBL] [Abstract][Full Text] [Related]
22. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
[TBL] [Abstract][Full Text] [Related]
23. [Algorithm of treatment of glucocorticoid induced osteoporosis--search for criteria].
Stepán J
Vnitr Lek; 2009 May; 55(5):448-54. PubMed ID: 19514609
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.
Nguyen TV; Center JR; Eisman JA
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):481-8. PubMed ID: 18971675
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
[TBL] [Abstract][Full Text] [Related]
26. [Recommendations of the Croatian Society for Rheumatology for prevention, diagnostics and treatment of post-menopausal osteoporosis].
Curković B; Grazio S; Babić-Naglić D; Anić B; Vlak T; Hanih M;
Reumatizam; 2008; 55(1):26-30. PubMed ID: 19024267
[TBL] [Abstract][Full Text] [Related]
27. Osteoporosis treatments and adverse events.
Solomon DH; Rekedal L; Cadarette SM
Curr Opin Rheumatol; 2009 Jul; 21(4):363-8. PubMed ID: 19412101
[TBL] [Abstract][Full Text] [Related]
28. Assessment of fracture risk.
Kanis JA; Johansson H; Oden A; McCloskey EV
Eur J Radiol; 2009 Sep; 71(3):392-7. PubMed ID: 19716672
[TBL] [Abstract][Full Text] [Related]
29. [Male osteoporosis].
Andersson S; Välimäki M
Duodecim; 2009; 125(10):1109-16. PubMed ID: 19585908
[TBL] [Abstract][Full Text] [Related]
30. Prevention of osteoporosis after breast cancer.
Reid DM
Maturitas; 2009 Sep; 64(1):4-8. PubMed ID: 19709826
[TBL] [Abstract][Full Text] [Related]
31. Prevention and treatment of senile osteoporosis and hip fractures.
Duque G; Demontiero O; Troen BR
Minerva Med; 2009 Feb; 100(1):79-94. PubMed ID: 19277006
[TBL] [Abstract][Full Text] [Related]
32. [Osteoporosis: fracture risk and management].
Rizzoli R
Rev Med Suisse; 2007 Jun; 3(115):1491-2. PubMed ID: 17682790
[No Abstract] [Full Text] [Related]
33. Commentary: bone density can be used to assess fracture risk.
Eastell R
BMJ; 1999 Mar; 318(7187):864-5. PubMed ID: 10223796
[No Abstract] [Full Text] [Related]
34. Corticosteroids: no drug prevention of fractures needed.
Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
[TBL] [Abstract][Full Text] [Related]
35. Osteoporosis: management and densitometry for orthopaedic surgeons.
Gehrig LM; Collinge C; Kaufman J; Lane JM; O'Connor MI; Tosi LL
Instr Course Lect; 2009; 58():805-15. PubMed ID: 19385588
[TBL] [Abstract][Full Text] [Related]
36. Corticosteroids and fractures: a close encounter of the third cell kind.
Manolagas SC
J Bone Miner Res; 2000 Jun; 15(6):1001-5. PubMed ID: 10841168
[No Abstract] [Full Text] [Related]
37. Epidemiology of glucocorticoid-induced osteoporosis.
Civitelli R; Ziambaras K
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):2-6. PubMed ID: 18791344
[TBL] [Abstract][Full Text] [Related]
38. Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment.
Parés A; Guañabens N
Clin Liver Dis; 2008 May; 12(2):407-24; x. PubMed ID: 18456188
[TBL] [Abstract][Full Text] [Related]
39. Which treatment to prevent an imminent fracture?
Laura I; Felicia B; Alexia C; Aude M; Florence B; Murielle S; Rafik K; Jean-Jacques B; Pierre B
Bone Rep; 2021 Dec; 15():101105. PubMed ID: 34386562
[TBL] [Abstract][Full Text] [Related]
40. [Chronic respiratory failure and osteoporosis: a difficult problem to unravel].
Orcel P
Rev Mal Respir; 2001 Sep; 18(4 Pt 1):361-3. PubMed ID: 11547239
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
